Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats

• Marco Pravetoni ,

  * E-mail: prave001@umn.edu

  Affiliations Minneapolis Medical Research Foundation, Minneapolis, Minnesota, United States of America, University of Minnesota, School of Medicine, Department of Medicine, Minneapolis, Minnesota, United States of America, University of Minnesota, School of Medicine, Department of Pharmacology, Minneapolis, Minnesota, United States of America, University of Minnesota, Center for Immunology, Minneapolis, Minnesota, United States of America

  ⨯
• Jeffrey S. Vervacke,

  Affiliation University of Minnesota, Department of Chemistry, Minneapolis, Minnesota, United States of America

  ⨯
• Mark D. Distefano,

  Affiliation University of Minnesota, Department of Chemistry, Minneapolis, Minnesota, United States of America

  ⨯
• Ashli M. Tucker,

  Affiliation Minneapolis Medical Research Foundation, Minneapolis, Minnesota, United States of America

  ⨯
• Megan Laudenbach,

  Affiliation Minneapolis Medical Research Foundation, Minneapolis, Minnesota, United States of America

  ⨯
• Paul R. Pentel

  Affiliations Minneapolis Medical Research Foundation, Minneapolis, Minnesota, United States of America, University of Minnesota, School of Medicine, Department of Medicine, Minneapolis, Minnesota, United States of America, University of Minnesota, School of Medicine, Department of Pharmacology, Minneapolis, Minnesota, United States of America

  ⨯